NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer.
Konrad SM, Schwamborn K, Krüger A, Honert K, Schmitt M, Hellmann D, Schmalfeldt B, Meindl A, Kiechle M, Quante AS, Brambs C, Grill S, Ramser J.
Konrad SM, et al. Among authors: brambs c.
Biomark Med. 2022 Oct;16(14):1029-1041. doi: 10.2217/bmm-2021-0781. Epub 2022 Nov 29.
Biomark Med. 2022.
PMID: 36444691